Cargando…

Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia – A novel fumarylacetoacetate hydrolase (FAH) intronic disease-causing variant

Tyrosinemia type 1 (HT1) is an inborn error of tyrosine catabolism that leads to severe liver, kidney, and neurological dysfunction. Newborn screening (NBS) can enable a timely diagnosis and early initiation of treatment. We presented the follow up of the only two Slovenian patients diagnosed with H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikonja, Jaka, Brecelj, Jernej, Zerjav Tansek, Mojca, Repic Lampret, Barbka, Drole Torkar, Ana, Klemencic, Simona, Lipovec, Neza, Stefanova Kralj, Valentina, Bertok, Sara, Kovac, Jernej, Faganel Kotnik, Barbara, Tesarova, Marketa, Remec, Ziga Iztok, Debeljak, Marusa, Battelino, Tadej, Groselj, Urh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856938/ https://www.ncbi.nlm.nih.gov/pubmed/35242570 http://dx.doi.org/10.1016/j.ymgmr.2021.100836

Ejemplares similares

Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program
por: Remec, Ziga I., et al.
Publicado: (2021)

Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH(4))-responsiveness in patients with hyperphenylalaninemia
por: Lampret, Barbka Repic, et al.
Publicado: (2022)

Optimizing the Phenylalanine Cut-Off Value in a Newborn Screening Program
por: Perko, Dasa, et al.
Publicado: (2022)

Precocious puberty in a girl with 3-methylglutaconic aciduria type 1 (3-MGA-I) due to a novel AUH gene mutation
por: Bizjak, Neli, et al.
Publicado: (2020)

Comparison of Tandem Mass Spectrometry and the Fluorometric Method—Parallel Phenylalanine Measurement on a Large Fresh Sample Series and Implications for Newborn Screening for Phenylketonuria
por: Perko, Dasa, et al.
Publicado: (2023)

Expanded Newborn Screening Program in Slovenia using Tandem Mass Spectrometry and Confirmatory Next Generation Sequencing Genetic Testing
por: Lampret, Barbka Repič, et al.
Publicado: (2020)

Clinical and genetic characteristics of a patient with phosphoribosyl pyrophosphate synthetase 1 deficiency and a systematic literature review
por: Štajer, Katarina, et al.
Publicado: (2023)

Medium-chain acyl-CoA dehydrogenase deficiency: Two novel ACADM mutations identified in a retrospective screening
por: Smon, Andraz, et al.
Publicado: (2018)

Next-Generation Sequencing in Newborn Screening: A Review of Current State
por: Remec, Ziga I., et al.
Publicado: (2021)

Reye Syndrome with Severe Hyperammonemia and a Good Neurological Outcome
por: Pribožič, Lucija, et al.
Publicado: (2021)

Compound Heterozygote Mutation in the SMPD1 Gene Leading to Nieman-Pick Disease Type A
por: Kavčič, Alja, et al.
Publicado: (2022)

A case report of short-chain acyl-CoA dehydrogenase deficiency (SCADD)
por: Lampret, Barbka Repic, et al.
Publicado: (2015)

Therapy-type related long-term outcomes in mucopolysaccaridosis type II (Hunter syndrome) – Case series
por: Zerjav Tansek, Mojca, et al.
Publicado: (2021)

Current Status of Newborn Screening in Southeastern Europe
por: Koracin, Vanesa, et al.
Publicado: (2021)

Carotid Intima-Media Thickness in Healthy Children and Adolescents: Normative Data and Systematic Literature Review
por: Drole Torkar, Ana, et al.
Publicado: (2020)

Newborn Screening in a Pandemic—Lessons Learned
por: Mlinaric, Matej, et al.
Publicado: (2023)

Long-Term Follow-Up of Three Family Members with a Novel NNT Pathogenic Variant Causing Primary Adrenal Insufficiency
por: Krasovec, Tjasa, et al.
Publicado: (2022)

Selective Screening for Metabolic Disorders in the Slovenian Pediatric Population
por: Lampret, Barbka Repič, et al.
Publicado: (2015)

Two Cases With an Early Presented Proopiomelanocortin Deficiency—A Long-Term Follow-Up and Systematic Literature Review
por: Gregoric, Nadan, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease in a pediatric patient with heterozygous familial hypobetalipoproteinemia due to a novel APOB variant: a case report and systematic literature review
por: Molk, Neza, et al.
Publicado: (2023)

Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
por: Li, Li, et al.
Publicado: (2017)

Newborn Screening in Slovenia
por: ŠMON, Andraž, et al.
Publicado: (2015)

Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family
por: Sheth, Jayesh J., et al.
Publicado: (2012)

Clinical and Molecular Cytogenetic Characterisation of Children with Developmental Delay and Dysmorphic Features
por: BERTOK, Sara, et al.
Publicado: (2015)

Early Discovery of Children With Lysosomal Acid Lipase Deficiency With the Universal Familial Hypercholesterolemia Screening Program
por: Sustar, Ursa, et al.
Publicado: (2022)

Drafting a blueprint for the design of a rare disease ecosystem in Slovenia: Identifying salient opportunities and outlining policy recommendations
por: Stanimirovic, Dalibor, et al.
Publicado: (2021)

Towards a Comprehensive Strategy for the Management of Rare Diseases in Slovenia: Outlining an IT-Enabled Ecosystemic Approach
por: Stanimirovic, Dalibor, et al.
Publicado: (2021)

A patient with glycogen storage disease type 0 and a novel sequence variant in GYS2: a case report and literature review
por: Arko, Janez Jan, et al.
Publicado: (2020)

Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate
por: Macias, Iratxe, et al.
Publicado: (2019)

Analysis of Insulin Resistance Among Children and Adolescents in Slovenia With Hypercholesterolemia After Treatment With Statins
por: Groselj, Urh, et al.
Publicado: (2022)

Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Saho, Robert, et al.
Publicado: (2023)

A missense mutation (Q279R) in the Fumarylacetoacetate Hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation
por: Dreumont, Natacha, et al.
Publicado: (2001)

Central TSH Dysregulation in a Patient with Familial Non-Autoimmune Autosomal Dominant Hyperthyroidism Due to a Novel Thyroid-Stimulating Hormone Receptor Disease-Causing Variant
por: Suput Omladic, Jasna, et al.
Publicado: (2021)

Identification and functional characterization of a novel homozygous intronic variant in the fumarylacetoacetate hydrolase gene in a Chinese patient with tyrosinemia type 1
por: Chen, Jiao, et al.
Publicado: (2022)

Data highlighting effects of Ketogenic diet on cardiomyopathy and hepatopathy in Glycogen storage disease Type IIIA
por: Marusic, Tatiana, et al.
Publicado: (2020)

Anthropometry and bone mineral density in treated and untreated hyperphenylalaninemia
por: Zerjav Tansek, Mojca, et al.
Publicado: (2020)

Normalization of obstructive cardiomyopathy and improvement of hepatopathy on ketogenic diet in patient with glycogen storage disease (GSD) type IIIa
por: Marusic, Tatiana, et al.
Publicado: (2020)

Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant
por: Ibarra‐González, Isabel, et al.
Publicado: (2019)

Novel Insights Into Monogenic Obesity Syndrome Due to INPP5E Gene Variant: A Case Report of a Female Patient
por: Drole Torkar, Ana, et al.
Publicado: (2021)

Hypercholesterolemia in Two Siblings with Resistance to Thyroid Hormones Due to Disease-Causing Variant in Thyroid Hormone Receptor (THRB) Gene
por: Pajek, Maja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ct2m67i6vie0g6dhvfhqv1evlk